Search results
AstraZeneca to build $1.5-billion cancer drug plant in Singapore
Reuters via AOL· 7 days agoThe facility, which will be the drugmaker's first end-to-end ADC production site, will be supported...
AstraZeneca earmarks $1.5B for end-to-end ADC factory in Singapore
Endpoints News· 6 days agoAstraZeneca said on Monday morning it is building a new antibody-drug conjugate facility in...
AstraZeneca (LON:AZN) Earns “Buy” Rating from Shore Capital
ETF DAILY NEWS· 3 days agoShore Capital reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a research report report published on Tuesday morning, Marketbeat Ratings reports ...
AstraZeneca Targets $80B Revenue by 2030 Through Pipeline Expansion
Market Watch· 6 days agoBy Helena Smolak AstraZeneca has set out a target to grow revenue to $80 billion by 2030 as it aims to bolster its investment in technologies and platforms....
AstraZeneca to harness China's 'explosion' of innovation to boost cell therapy R&D
FierceBiotech· 5 days agoAstraZeneca’s growing presence in China will play a key role in the Big Pharma’s cell therapy...
AstraZeneca aims increase its annual revenue by 75% in its post-COVID era
Quartz· 5 days agoCambridge, U.K.-based pharmacuetical giant AstraZeneca announced an ambitious sales goal for the end of this decade, just as it pulls it COVID-19 vaccines off the shelves.
AstraZeneca kicks off 'new era of growth' with aim to hit $80 billion of sales by 2030
Morningstar· 6 days agoAstraZeneca on Tuesday outlined ambitions to almost double its sales over the next six years by launching 20 new medicines by 2030. In a statement, the Anglo-Swedish pharmaceutical ...
AstraZeneca’s fasenra asthma drug shows promise for COPD treatment
BioPharma-Reporter· 5 days agoThis approval extends Fasenra's availability to over 80 countries, including the US, EU, and Japan....
AstraZeneca to build $1.5-bln cancer drug plant in Singapore
Reuters· 6 days ago, opens new tab plans to build a $1.5 billion manufacturing facility in Singapore to produce a...
AstraZeneca Aims for $80 Billion in Sales by 2030
Bloomberg· 6 days agoHave a confidential tip for our reporters? AstraZeneca Plc aims to almost double sales to $80 billion by 2030 as Chief Executive Officer Pascal Soriot...